Perceptive LS (A), LLC is Director & 10% Owner at Lyra Therapeutics, Inc. (LYRA). They have made 1 open-market trade across 1 company since 2023, most recently 2023-05-31.
CIK 0001797811
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $18.0M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LYRA | 11,469,117 | $5.7M |
Shares reported on the most recent Form 4, priced at the 2023-06-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LYRA | BUY | 2023-05-31 | 2023-06-02 | $2.49 | $18.0M | -8.8% | +28.5% | +9.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.